Objective 16

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/35

encourage image

There's no tags or description

Looks like no tags are added yet.

36 Terms

1
New cards

M0

  • AML with minimal differentiation


2
New cards

M1

  • AML without maturation


3
New cards

M2

  • AML with maturation


4
New cards

M3

  • Acute promyelocytic leukemia


5
New cards

M4

  • Acute Myelomonocytic leukemia


6
New cards

M5

  • Acute monoblastic and monocytic leukemia


7
New cards

M6

  • Pure erythroid leukemia


8
New cards

M7

  • Acute megakaryoblastic Leukemia


9
New cards

What are the FAB classifications for Acute Myeloid Leukaemia?

  • M0: AML with minimal differentiation

  • M1: AML without maturation

  • M2: AML with maturation

  • M3: acute promyelocytic leukaemia

  • M4: Acute myelomonocytic leukemia

  • M5: Acute monoblastic and monocytic leukaemia

  • M6: Pure erythroid leukaemia

  • M7: Acute megakaryoblastic leukemia


10
New cards

What is the WHO classification for Myeloid Leukemia?

  • AML with recurrent genetic abnormalities

  • AML with meylodysplasia-related changes

  • Therapy-related myeloid neoplasms

  • AML-NOS

  • Myeloid sarcoma

  • Myeloid proliferation related to Down Syndrome

  • Acute Leukemias of ambiguous lineage


11
New cards
<p><strong>AML with Recurrent Genetic Abnormalities</strong></p><ul><li><p>t(8;21) (q22;q22);RUNX1/RUNX1T1 (fusion)</p></li></ul><p></p>

AML with Recurrent Genetic Abnormalities

  • t(8;21) (q22;q22);RUNX1/RUNX1T1 (fusion)


  • 5% of all AML cases

  • children and young adults

  • dysplastic granular cytoplasm

  • Auer rods

  • Pseudo Pelger-Huet cells

  • Hypogranulation

  • Eosinophilia

  • Monosomy 7

  • > 10% blasts

  • FAB M2


12
New cards
<p><strong>AML with Recurrent Genetic Abnormalities</strong></p><ul><li><p><strong>inv(16)(p13.1;q22.1) or t(16;16)(p13.1;q22); CBFB-MYH11</strong></p></li></ul><p></p>

AML with Recurrent Genetic Abnormalities

  • inv(16)(p13.1;q22.1) or t(16;16)(p13.1;q22); CBFB-MYH11


  • accounts for 5-8% of all AML cases

  • Myeloblasts, monoblasts, AMML, promyelocytes

  • eosinophilia with dysplastic changes

  • extramedullary disease

  • CNS

  • > 10% blasts

  • FAB 4


13
New cards
<p><strong>AML with Recurrent Genetic Abnormalities</strong></p><ul><li><p><strong>AML with t(15;17)</strong>(q22;q12); PML-RARA</p></li></ul><p></p>

AML with Recurrent Genetic Abnormalities

  • AML with t(15;17)(q22;q12); PML-RARA


  • known as acute promyelocytic leukemia (FAB M3)

  • 5-10% of AML cases

  • differentiation block at promyelocytic stage

  • Dx: detection of t(15;17) mutation

  • auer rods, DIC

  • microgranular variant - 30-40% APL

  • > 10% blasts

  • treatment

    • ATRA

    • Arsenic trioxide


14
New cards
<p><strong>AML with Recurrent Genetic Abnormalities</strong></p><ul><li><p>t(9;11)(p22;q23);MLLT3-MLL</p></li></ul><p></p>

AML with Recurrent Genetic Abnormalities

  • t(9;11)(p22;q23);MLLT3-MLL


  • 6% of AML cases

  • monoblasts

  • immature monocytes

  • large blasts, abundant cytoplasm

    • > 10% blasts

  • gingival, skin involvement

  • DIC


15
New cards
<p><strong>AML with Recurrent Genetic Abnormalities</strong></p><ul><li><p>t(6;9)(p23;q34);DEK-NUP214 rearrangement</p></li></ul><p></p>

AML with Recurrent Genetic Abnormalities

  • t(6;9)(p23;q34);DEK-NUP214 rearrangement


  • > 10% peripheral blood or BM blasts with/without monocytic features

  • associated with basophilia / multilineage dysplasia

  • poor prognosis

  • low WBC count


16
New cards

Describe the AMLs with Recurrent Genetic Abnormalities

  • 7 types involving a translocation or inversion

  • variable frequency

  • DIC with t(15,17) , less frequent with t(9;11)

  • favorable prognosis in:

    • AML t(8;21)

    • Inv(16)

    • t(15;17)

    • t(9;11)


17
New cards
<p>Describe <strong>AML with Myelodysplasia related changes</strong></p>

Describe AML with Myelodysplasia related changes

  • in older adults (poor prognosis)

  • > 20% blasts w’ multilineage dysplasia

  • history of: MDS, MPN, MDS associated abnormality

  • neutrophil hypergranulation

  • Pseudo Pelger-Huet

  • 7q-, 5q-

  • dysplastic megakaryocytes

  • ringed sideroblast

  • vacuoles in erythroblasts

  • pancytopenia


18
New cards

Describe therapy-related Myeloid Neoplasms (TR-MN)

  • comprise 10-20% AML, MDS, MPN

  • median age: 61 yrs

  • treatment:

    • alkylating agents, radiation, topoisomerase II inhibitor

  • poor prognosis

    • t(9;22)

    • 11q23(MLL)

    • 11p15(NUP98)


19
New cards
<p>Describe <strong>AML with Minimal Differentiation </strong></p>

Describe AML with Minimal Differentiation

  • Immunophenotype

    • CD13+, CD33+, CD34+, CD17+

  • Auer rods absent

  • lack of cellular maturation

  • negative results with MPO/ SBB

  • comprises < 5% of AML


20
New cards
<p>Describe <strong>AML without Maturation </strong></p>

Describe AML without Maturation

  • blasts comprise 90% of nonerythroid cells in BM

  • fewer than 10% of leukocytes show maturation to promyelocyte stage

  • Auer rods present

  • Positive MPO and SBB

  • Immunophenotype

    • CD13+,CD33+, CD117+,CD34+


21
New cards
<p>Describe <strong>AML with Maturation </strong></p>

Describe AML with Maturation

  • > 20% blasts

  • at least 10% maturing cells of neutrophil lineage

  • fewer than 20% monocytic lineage

  • auer rods present


22
New cards

Which classification system uses M0-M7 for AML?

  • FAB


23
New cards

What WHO subtype is associated with this.

  • Philadelphia chromosome. Associated with a poorer prognosis.


  • t(9;22) - BCR-ABL1


24
New cards

What WHO subtype is associated with this.

  • Often occurs in infants; associated with CNS involvement and organomegaly.


  • t(v;11q23.3) – KMT2A


25
New cards

What WHO subtype is associated with this.

  • Common in childhood ALL; generally favorable prognosis.


  • t(12;21) – ETV6-RUNX1


26
New cards

What WHO subtype is associated with this.

  • Cells have TOO MANY chromosomes (more than 50); generally favorable prognosis in children.


  • Hyperdiploidy


27
New cards

What WHO subtype is associated with this.

  • Cells have TOO FEW chromosomes (fewer than 46); generally poor prognosis.


  • Hypodiploidy


28
New cards

What WHO subtype is associated with this.

  • Rare subtype; may be associated with eosinophilia.


  • t(5;14) – IL3-IGH


29
New cards

What WHO subtype is associated with this.

  • Genetic abnormality involving chromosomes 1 and 19.


  • t(1;19) – TCF3-PBX1


30
New cards

What are the B-cell ALL WHO subtypes?

  • t(9;22) – BCR-ABL1

  • t(v;11q23.3) – KMT2A

  • t(12;21) – ETV6-RUNX1

  • Hyperdiploidy

  • Hypodiploidy

  • t(5;14) – IL3-IGH

  • t(1;19) – TCF3-PBX1


31
New cards

Describe this WHO category of AML.

  • AML with recurrent genetic abnormalities


  • AML caused by specific, recognizable genetic changes or chromosome abnormalities.


32
New cards

Describe this WHO category of AML.

  • AML with myelodysplasia-related changes


  • AML associated with abnormal-looking blood cell development, often with a history of MDS or MPN


33
New cards

Describe this WHO category of AML.

  • Therapy-related myeloid neoplasms (TR-MN)


  • AML or another myeloid disease that develops after previous chemotherapy or radiation treatment.


34
New cards

Describe this WHO category of AML.

  • AML-NOS


  • AML that doesn't fit into one of the more specifically defined categories


35
New cards

Describe this WHO category of AML.

  • Myeloid sarcoma


  • A collection of cancerous myeloid cells forming a tumor outside the bone marrow.


36
New cards

Describe this WHO category of AML.

  • Acute leukemias of ambiguous lineage


  • Leukemia cells that cannot be clearly classified as either myeloid or lymphoid, or show characteristics of both.